Abrdn PLC Pacira Bio Sciences, Inc. Transaction History

Abrdn PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$25.5 - $31.51 $1.64 Million - $2.03 Million	64,433 Added 11.82%	609,351 $17.4 Million
Q1 2024 May 08, 2024	BUY	$27.7 - $35.48 $2.67 Million - $3.41 Million	96,227 Added 21.45%	544,918 $15.9 Million
Q4 2023 Jan 31, 2024	BUY	$26.32 - $34.31 $1.48 Million - $1.92 Million	56,081 Added 14.28%	448,691 $15.1 Million
Q3 2023 Nov 06, 2023	SELL	$30.68 - $40.09 $2.57 Million - $3.36 Million	-83,811 Reduced 17.59%	392,610 $12 Million
Q2 2023 Jun 20, 2024	SELL	$36.12 - $47.5 $2.47 Million - $3.25 Million	-68,497 Reduced 12.57%	476,421 $19.1 Million
Q2 2023 Aug 04, 2023	BUY	$36.12 - $47.5 $17.2 Million - $22.6 Million	476,421 New	476,421 $19.1 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

Stay updated on Abrdn PLC with notifications on news.